Bordetella pertussis toxoid antigen (formaldehyde inactivated) Completed Phase 4 Trials for Infants / Vaccines, Pneumococcal / Drug Therapy, Combination / Fever, Chemically Induced Prevention

Indications	Status	Purpose	Phase
DBCOND0057034 (Infants) DBCOND0033872 (Vaccines, Pneumococcal) DBCOND0033874 (Drug Therapy, Combination) DBCOND0033873 (Fever, Chemically Induced)	Completed	Prevention	4

clinicaltrials.gov Identifier	Title	Drugs
NCT00294294	Study Evaluating Treatment of Fever in Children Who Have Been Vaccinated With Prevenar and Infanrix Hexa	Bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated) (DB10788) Bordetella pertussis pertactin antigen (DB10789) Bordetella pertussis toxoid antigen (formaldehyde inactivated) (DB14388) Clostridium tetani toxoid antigen (formaldehyde inactivated) (DB10583) Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) (DB10584) Haemophilus influenzae b polysaccharide-tetanus conjugate (DB15876) Hepatitis B Vaccine (Recombinant) (DB11627) Poliovirus type 1 antigen (formaldehyde inactivated) (DB10795) Poliovirus type 2 antigen (formaldehyde inactivated) (DB10796) Poliovirus type 3 antigen (formaldehyde inactivated) (DB10797)